Acciones Harpoon Therapeutics, Inc.
Acciones
HARP
US41358P2056
Biotecnología e investigación médica
Último transcript sobre Harpoon Therapeutics, Inc.
Directores | Puesto | Edad | Desde |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Frank Lanza
DFI | Director of Finance/CFO | 62 | 01/04/19 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,26 % | 103 mil M | |
+1,41 % | 95,71 mil M | |
+0,52 % | 22,02 mil M | |
-17,84 % | 20,9 mil M | |
-8,72 % | 17,85 mil M | |
-42,83 % | 16,21 mil M | |
-17,63 % | 15,52 mil M | |
+4,55 % | 13,86 mil M | |
+32,11 % | 12,04 mil M |